Accelerated biological aging increases the risk of short- and long-term stroke prognosis in patients with ischemic stroke or TIA.

Mengxing Wang, Hongyi Yan, Yanli Zhang, Qi Zhou, Xia Meng, Jinxi Lin, Yong Jiang, Yuesong Pan, Yongjun Wang

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Centre for Neurological Diseases, Beijing, China. · pubmed

Paper

Abstract

Biological age (BA), an integrated measure of physiological aging, has a clear link to stroke. There is a paucity of long-term longitudinal studies about the association between accelerated biological age and stroke prognosis in patients with previous strokes, and the differences in the predictive ability of various BA indicators calculated from clinical biochemistry biomarkers for future stroke outcomes are still unknown. To evaluate the role of three accelerated BA indicators for short- and long-term prognosis of patients with ischemic stroke or transient ischemic attack (TIA), and to identify the most appropriate predictor.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the relationship between accelerated biological aging and stroke prognosis, which is relevant to understanding aging processes and their implications for health outcomes. However, it primarily focuses on stroke prognosis rather than addressing the root causes of aging or proposing interventions for lifespan extension. The findings may contribute to the field but are more of a solid research effort with limited broader impact on longevity science.

Author of this paper? Send a correction.